Interferon beta-1a
Interferon beta-1a
Interferon beta-1a (pronounced as in-ter-FEER-on BAY-tuh-1a) is a type of protein and biopharmaceutical that is used to treat multiple sclerosis (MS). It is produced by mammalian cells that have been genetically engineered to produce it.
Etymology
The term "Interferon" is derived from the word "interfere" as it was discovered due to its ability to "interfere" with viral replication. The "beta-1a" refers to the specific subtype of interferon.
Usage
Interferon beta-1a is used to treat relapsing forms of Multiple Sclerosis, a chronic disease that affects the central nervous system. It is not a cure for MS but it can help to slow the progression of the disease and manage symptoms.
Mechanism of Action
Interferon beta-1a works by reducing inflammation and preventing the damage that inflammation can cause to the protective covering of nerve fibers in the brain and spinal cord.
Related Terms
See Also
External links
- Medical encyclopedia article on Interferon beta-1a
- Wikipedia's article - Interferon beta-1a
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski